Respiratory Syncytial Virus - Epidemiology Forecast to 2030

2021-08-31
Price :
Published : Aug-2021
No. of Pages : 40
Table of Contents
1 Respiratory Syncytial Virus: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.1.1 Risk Factors and Comorbidities
2.2 Global and Historical Trends
2.3 Forecast Methodology
2.3.1 Sources
2.3.2 Forecast Assumptions and Methods
2.4 Epidemiological Forecast for RSV Prophylactic Population (2020-2030)
2.4.1 Number of Preterm Births by Gestational Age
2.4.2 Preterm Infants with CLD
2.4.3 Number of Live Births with Hemodynamically Significant Heart Disease and Congenital Lung Disease
2.4.4 Diagnosed Prevalent Cases of DMD
2.4.5 Number of Diagnosed Prevalent Cases of SMA
2.4.6 Number of Third-Trimester Pregnant Women
2.4.7 Number of Adults Living in Nursing Homes/Long-Term Care Institutions
2.5 Discussion
2.5.1 Epidemiological Forecast Insight
2.5.2 COVID-19 Impact
2.5.3 Limitations of the Analysis
2.5.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us

List of Tables
Table 1: 8MM, Summary of the Prophylactic Population in 2020
Table 2: Summary of Newly Added Data Types
Table 3: Summary of Updated Data Types
Table 4: Risk Factors for Severe RSV

List of Figures
Figure 1: 8MM, Rate of Preterm Births (per 1,000 Live Births), 2020-2030
Figure 2: 8MM, Percentage of Adults Living in Long-Term Care, Ages ?55 Years, 2020-2030
Figure 3: 8MM, Sources Used to Forecast the Number of Preterm Births
Figure 4: 8MM, Sources Used to Forecast the Number of Preterm Births with CLD
Figure 5: 8MM, Sources Used to Forecast the Number of Live Births with Hemodynamically Significant Heart Disease
Figure 6: 8MM, Sources Used to Forecast the Number of Live Births with Congenital Lung Disease
Figure 7: 8MM, Sources Used to Forecast the Diagnosed Prevalent Cases of DMD
Figure 8: 8MM, Sources Used to Forecast the Diagnosed Prevalent Cases of SMA
Figure 9: 8MM, Sources Used to Forecast the Number of Third-Trimester Pregnancies
Figure 10: 8MM, Sources Used to Forecast the Number of Adults Living in Long-Term Care
Figure 11: 8MM, Number of Preterm Births by Gestational Age, N, 2020
Figure 12: 8MM, Number of Preterm Infants with CLD, N, 0-Year, 2020-2030
Figure 13: 8MM, Number of Live Births with Hemodynamically Significant Heart Disease and Congenital Lung Disease, 2020, 0-Year
Figure 14: 8MM, Diagnosed Prevalent Cases of DMD in Boys, Ages 0-2 Years, 2020-2030
Figure 15: 8MM, Diagnosed Prevalent Cases of SMA, Boys and Girls, Ages 0-2 Years, 2020-2030
Figure 16: 8MM, Number of Third-Trimester Pregnant Women, N, 2020-2030
Figure 17: 8MM, Number of Adults Living in Care Institutions, Ages ?55 Years, N, 2020-2030
Filed in: Pharmaceutical
Publisher : GlobalData